Bell Pharmaceuticals, Inc
Bell Pharmaceuticals, Inc lists 6 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 15579-200 | JET ALERT Double Strength Tablet, Coated | Caffeine 200 mg/1 | OTC |
| 15579-201 | JET ALERT Regular Strength Tablet, Coated | Caffeine 100 mg/1 | OTC |
| 15579-828 | Jet-Asleep Double Strength Night Time Sleep Aid Tablet | Diphenhydramine Hydrochloride 50 mg/1 | OTC |
| 15579-105 | Otix Ear Relief Ear Drops Solution/ Drops | Chamomile 10 [hp_X]/mL; Mercurius Solubilis 15 [hp_X]/mL; Sulfur 12 [hp_X]/mL | OTC |
| 15579-838 | Otix Ear wax Removal Drops Solution/ Drops | Carbamide Peroxide 65 mg/mL | OTC |
| 15579-839 | Otix Ear wax Removal System Ear wax and Bulb Kit | OTC |
Recalls by Bell Pharmaceuticals, Inc
- D-0688-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). - D-0687-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). - D-0686-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). - D-0685-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). - D-0684-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). - D-0683-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). - D-0682-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). - D-0681-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). - D-0680-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). - D-0679-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). - D-0678-2026 Jul 22, 2026 · Class II
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).